Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by harposon Aug 18, 2017 7:32am
253 Views
Post# 26595213

Phil Davis post

Phil Davis postI also want to thank you for the well thought out meaningful post. I found it to be insightful in many areas. I will quibble on a few things. First of all, have I missed something? Are they changing the 30 day procedure to MRI instead of CT scan. You would be the first to tell us that those are two completely different procedures with one using X-rays and the other magnets. The first three were CT scans at 30 days.
I will also argue that the progress shown so far should be characterized much higher than "clinical potential". Dr Kulkarni said if " if two or three of the first nine" had a positive outcome, "that would be phenomenal." We already have three for three and we have six to go. Remember, recurrence happens in 80 percent of patients after Scraping and I think the first round of BCG. Our patients were as Dr K called them, " the worst of the worst". They failed two complete rounds of BCG which each round is several different procedures. 
Did you pick next May to say that will be the time everybody knows about TLT 's treatment because that is when the urological congress is? My personal belief is that the time when the company will be known to everybody will be sooner than that and possibly as early as December if the results from the cytoscophy is anywhere near nine for nine.
Lastly it is impossible for me to imagine that the big pharma could be so much in the dark. Again, Dr. Kulkarni is also the lead investigator on mercks Keytruda phase 2 for NMIBC. Dr black that  Bencro mentioned yesterday is Roche lead on NMIBC. They are all watching each other very closely. If we follow it as closely as we do, they follow it much closer because of the stakes involved for them. I will agree that we should be seeing higher volume as a result of all that and I cannot explain it. It seems that they would all be positioning based on what's happened so far. It just seems unimaginable since a subsidiary of Merck manufactures 1433 that they would be unaware of any results released so far. 
I would have to write as much as you did to say how I appreciated the vast majority of what you posted. This board would be so much better if it was confined to thought-provoking discussion like your wonderful post.

Bullboard Posts